BALL KRISTINE M

Insider profile

BALL KRISTINE M's trades of Oruka Therapeutics Inc's stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
408.39
Quantity 21,582 +8.5%
Value US$3,897,205
Transaction date
Planned sale
Price
211.58
Quantity 12,442 +46.6%
Value US$1,080,938
Transaction date
Planned sale
Price
281.15
Quantity 63,596 -31.2%
Value US$1,207,522
Transaction date
Planned sale
Price
104.16
Quantity 2,039 -13.2%
Value US$212,387
Transaction date
Planned sale
Price
103.09
Quantity 1,300 -7.7%
Value US$134,021
Transaction date
Planned sale
Price
102.10
Quantity 1,196 -6.6%
Value US$122,108
Transaction date
Proposed sale
Price
107.17
Quantity 18,000
Value US$1,929,060
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-13 2026-11-12 PlS Planned sale
21,582 +8.5%
408.39
US$3,897,205
21,582 +8.5% 408.39 US$3,897,205
2026-11-13 2026-11-12 PlS Planned sale
12,442 +46.6%
211.58
US$1,080,938
12,442 +46.6% 211.58 US$1,080,938
2026-11-13 2026-11-12 PlS Planned sale
63,596 -31.2%
281.15
US$1,207,522
63,596 -31.2% 281.15 US$1,207,522
2026-11-13 2026-11-12 PlS Planned sale
2,039 -13.2%
104.16
US$212,387
2,039 -13.2% 104.16 US$212,387
2026-11-13 2026-11-12 PlS Planned sale
1,300 -7.7%
103.09
US$134,021
1,300 -7.7% 103.09 US$134,021
2026-11-13 2026-11-12 PlS Planned sale
1,196 -6.6%
102.10
US$122,108
1,196 -6.6% 102.10 US$122,108
2026-11-12 2026-11-12 PrS Proposed sale
18,000
107.17
US$1,929,060
18,000 107.17 US$1,929,060